FDA Approves Easier-to-Use Version of AIDS Drug ddI

Strategic Insights -

The US Food and Drug Administration has given the green light to a new, easier-to-use version of the AIDS drug ddI, which may ease patient complaints about the medicine's difficulty to swallow. The new version is a once-a-day capsule, Videx EC, which eliminates the need for patients to chew or dissolve two large, bitter-tasting pills twice a day. This change is expected to alleviate side effects such as diarrhea and gastrointestinal issues.

Key Takeaways:

  • The FDA approved a new version of the AIDS drug ddI, which is easier to swallow than the previous version.
  • The new version, Videx EC, is a once-a-day capsule that eliminates the need for patients to chew or dissolve bitter-tasting pills twice a day.
  • The FDA believes the new version may cause fewer dangerous interactions with other medications due to the absence of a buffering ingredient in the chewable version.
  • Manufacturer Bristol-Myers Squibb claims that the special coating on the new version may reduce gastrointestinal side effects.
  • Although Bristol-Myers did not provide a specific date for the release of Videx EC or its pricing, it is expected to be available soon.
  • The FDA approval of the new ddI version is expected to improve patient compliance and quality of life for AIDS patients.

Statistics:

  • 2 large, bitter-tasting ddI pills were previously required to be chewed or dissolved in water twice a day.
  • The new Videx EC capsule is a once-a-day version of the drug.
  • The FDA approved the new ddI version on October 31, 2000.
  • It is estimated that the new version may cause fewer gastrointestinal side effects due to the absence of a buffering ingredient.

Sources:

  • "FDA Approves New AIDS Drug." AIDS Weekly, NewsRx.com, 20 Nov. 2000.